Park R - Search Results

1

S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model.

Lu SC, Ramani K, Ou X, Lin M, Yu V, Ko K, Park R, Bottiglieri T, Tsukamoto H, Kanel G, French SW, Mato JM, Moats R, Grant E. Lu SC, et al. Among authors: park r. Hepatology. 2009 Aug;50(2):462-71. doi: 10.1002/hep.22990. Hepatology. 2009. PMID: 19444874 Free PMC article.

2

Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.

Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. Liao CP, et al. Among authors: park r. Cancer Res. 2007 Aug 1;67(15):7525-33. doi: 10.1158/0008-5472.CAN-07-0668. Cancer Res. 2007. PMID: 17671224

3

Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide.

Chen X, Park R, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Moats RA, Bading JR, Laug WE, Conti PS. Chen X, et al. Among authors: park r. Mol Imaging Biol. 2006 Jan-Feb;8(1):9-15. doi: 10.1007/s11307-005-0024-1. Mol Imaging Biol. 2006. PMID: 16315003

4

Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice.

Sodir NM, Chen X, Park R, Nickel AE, Conti PS, Moats R, Bading JR, Shibata D, Laird PW. Sodir NM, et al. Among authors: park r. Cancer Res. 2006 Sep 1;66(17):8430-8. doi: 10.1158/0008-5472.CAN-06-1437. Cancer Res. 2006. PMID: 16951153

5

18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.

Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats R, Laug WE, Conti PS. Chen X, et al. Among authors: park r. Nucl Med Biol. 2004 Feb;31(2):179-89. doi: 10.1016/j.nucmedbio.2003.10.002. Nucl Med Biol. 2004. PMID: 15013483

6

Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression.

Cai H, Li Z, Huang CW, Shahinian AH, Wang H, Park R, Conti PS. Cai H, et al. Among authors: park r. Bioconjug Chem. 2010 Aug 18;21(8):1417-24. doi: 10.1021/bc900537f. Bioconjug Chem. 2010. PMID: 20666401

7

A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α-positive tumors.

Sahu D, Zhao Z, Tsen F, Cheng CF, Park R, Situ AJ, Dai J, Eginli A, Shams S, Chen M, Ulmer TS, Conti P, Woodley DT, Li W. Sahu D, et al. Among authors: park r. Mol Biol Cell. 2012 Feb;23(4):602-13. doi: 10.1091/mbc.E11-06-0575. Epub 2011 Dec 21. Mol Biol Cell. 2012. PMID: 22190738 Free PMC article.

8

Effect of Androgen on Normal Biodistribution of [¹⁸F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice.

Jadvar H, Park R, Yap LP, Chen K, Hughes L, Conti P. Jadvar H, et al. Among authors: park r. Anticancer Res. 2017 Feb;37(2):475-479. doi: 10.21873/anticanres.11339. Anticancer Res. 2017. PMID: 28179292 Free PMC article.

9

PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies.

Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Liu S, et al. Among authors: park r. J Nucl Med. 2013 Jul;54(7):1094-100. doi: 10.2967/jnumed.112.116822. Epub 2013 May 10. J Nucl Med. 2013. PMID: 23667241 Free article. Review.

10

[18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations.

Jadvar H, Yap LP, Park R, Li Z, Chen K, Hughes L, Kouhi A, Conti P. Jadvar H, et al. Among authors: park r. Mol Imaging. 2012 Sep-Oct;11(5):426-32. Mol Imaging. 2012. PMID: 22954187 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,216 results

Search Page

Filters